Explore rapid and sustained therapies for ME/CFS that has been resistant to conventional treatments
Clarus Health offers the following therapies for safe and fast-acting relief from myalgic encephalomyelitis (ME/CFS):
These therapies aim to address the root causes of ME/CFS, which is different in different patients. They have decades of clinical, off-label use despite not having FDA approval for the treatment of ME/CFS.
Chronic fatigue syndrome, also called myalgic encephalomyelitis (ME/CFS), can be a devastating and complex condition that affects approximately 0.9% of the global population. Unfortunately, many medical professionals are skeptical about the validity of the condition leading to delayed diagnosis, misdiagnosis, or ineffective treatment prescriptions (like antidepressants).
ME/CFS can affect multiple organs and is characterized by at least six months of moderate-to-severe symptoms affecting three core areas:
Other common symptoms can include:
These varied symptoms are a result of dysregulation across the neuro-immune system, hormonal regulation, and even cardiovascular and gastrointestinal systems. You can learn more about ME/CFS in our detailed article.
ME/CFS can have different triggers, including:
Stellate ganglion block (SGB) offers new hope for those suffering from ME/CFS by targeting a root cause: nervous system imbalance. By calming overactive “fight-or-flight” nerves, SGB can help restore balance to the body’s stress response—often linked to chronic fatigue, brain fog, and unrefreshing sleep. Patients report feeling more energized, clear-headed, and rested, making SGB a promising option for those who haven’t found relief through conventional treatments.
SGB has specifically shown promise in treating:
You can learn more about the Stellate Ganglion Block for ME/CFS here.
IV ketamine is emerging as a powerful option for ME/CFS relief by working at the intersection of pain, fatigue, and nervous system dysfunction. As a rapid-acting NMDA receptor modulator, ketamine helps calm overactive nerve signaling and supports neuroplasticity and energy regulation, two areas potentially disrupted in ME/CFS. Many patients report improvements in energy, mental clarity, and pain levels after treatment—offering a new path forward for those who feel stuck and exhausted despite trying everything else. Ketamine infusion therapy is specifically helpful for:
You can learn more about IV Ketamine for ME/CFS here.
NAD+ is a key regulator of energy metabolism in the body. NAD+ therapy can support ME/CFS recovery by targeting impaired mitochondrial energy production, which in often poisoned in ME/CFS. By restoring cellular NAD+ levels, these infusions help enhance ATP generation, reduce neuroinflammation, improve mitochondrial resilience, and reduce oxidative stress—all of which may contribute to improved energy, sleep efficiency, mental clarity, and cognitive function in people with ME/CFS. Patients heavily burdened with cognitive impairment, energy depletion, and exercise intolerance may be candidates for:
Genetic testing offers a powerful tool to help personalize care for individuals with ME/CFS by uncovering underlying vulnerabilities in key biological pathways. Variants in the following genes may contribute to ME/CFS symptoms:
Abnormalities in these pathways can shed light on why certain patients experience profound fatigue, cognitive dysfunction, and sleep disturbances. This allows for targeted interventions—such as mitochondrial support, methylation cofactors, specific anti-inflammatory therapies, or gut-healing protocols. Identifying these genetic susceptibilities allows for more precise and efficient treatment strategies tailored to the individual biology of each ME/CFS patient.
Antioxidant supplementation can play a critical role in managing ME/CFS by targeting one of its key underlying mechanisms: oxidative stress and mitochondrial dysfunction. This is particularly observed in patients with long COVID. Several vital nutrients are reduced in some patients with ME/CFS:
IV infusions bypass the gastrointestinal tract to provide 100% bioavailability for faster and more reliable blood levels. This is particularly valuable for patients with malabsorption issues, chronic stress, or fluctuating hormone levels that may impair nutrient uptake. Together, these antioxidants may help reduce inflammation, improve cellular resilience, and support clearer thinking and improved energy in individuals with ME/CFS.
Dr. Kaveh’s holistic approach to relieving ME/CFS includes 3 steps:
Contact Clarus Health with any questions about how SGB, IV Ketamine, NAD+ and antioxidant therapies can help relieve symptoms of ME/CFS.